Categorizing immune responders with fusion metrics and simulation for association to survival & progression free survival with immune response in HLA-A2+ patients with GBM from a phase 2 trial of dendritic cell (DC) immunotherapy (ICT-107).

Event Name/Location

The 21st Annual Scientific Meeting and Education Day for the Society for Neuro- Oncology; 2016 November 17-20; Scottsdale, AZ

Presentation Date

11-2016

Document Type

Conference Presentation

Presenters / Authors

Radleigh Santos, Torrey Pines Institute for Molecular StudiesFollow
Clemencia Pinilla, Torrey Pines Institute for Molecular Studies
Steve J. Swanson
Anthony Gringeri, ImmunoCellular Therapeutics Ltd
John Yu

NSUWorks Citation

Santos, Radleigh; Pinilla, Clemencia; Swanson, Steve J.; Gringeri, Anthony; and Yu, John, "Categorizing immune responders with fusion metrics and simulation for association to survival & progression free survival with immune response in HLA-A2+ patients with GBM from a phase 2 trial of dendritic cell (DC) immunotherapy (ICT-107)." (2016). Mathematics Faculty Proceedings, Presentations, Speeches, Lectures. 377.
https://nsuworks.nova.edu/cnso_math_facpres/377